Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ONCY

+ Watchlist+ Portfolio

Oncolytics Biotech Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.44
52-Week Range
$0.33 – $1.30
Market Cap
$53.18M
P/E (TTM)
—
EPS (TTM)
-0.33
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-211.24%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
1.35
Debt/Equity
—
Total Debt
$448.00K
Free Cash Flow
$-12.01M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$43.51M

Market Snapshot

About

Oncolytics Biotech Inc. is a Canadian clinical-stage biopharmaceutical company developing oncolytic viruses to treat cancer. Lead product uses viruses to selectively kill cancer cells while stimulating immune response.